Analgesic Therapy

PreclinicalSmall molecule

UUniversity of Padova, School of Dental Medicine

Analgesic Therapy is one of 4 small molecule programs targeting Connective Tissue Graft. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Connective Tissue GraftCompleted

Connective Tissue GraftPreclinical

Completed

Competition

Competitive Landscape

3 competitors in Connective Tissue Graft

#DrugCompanyPhaseTrials

Platelet Rich Fibrin

GGovernment Dental College and Research Institute, Bangalore

Preclinical

1 2

Acellular Dermal Matrix

UUniversity of Iowa

Preclinical

1 3

Amnion Chorion Membrane

MMinia University

Preclinical

1 4

Analgesic Therapy

UUniversity of Padova, School of Dental Medicine

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Connective Tissue Graft1 trial

Morbidity and Coverage Outcome With Connective Tissue Graft Used With Coronally Advanced Flap and Tunneling Technique

Completed·UUniversity of Padova, School of Dental Medicine·N/A·NCT02269748·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Analgesic Therapy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Analgesic Therapy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Analgesic Therapy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Padova, School of Dental Medicine company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Padova, School of Dental Medicine

Analgesic Therapy

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Connective Tissue Graft1 trial

References

Drug Info

Quick Facts

Related News